Dr Lal Pathlabs informs about schedule of analyst meet

04 Sep 2019

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr Lal Pathlabs has informed about the details of proposed schedule of Analyst/Institutional Investor meeting. 

The above information is a part of company’s filings submitted to BSE.

Related Dr. Lal Pathlabs Ltd. Links:

Dr Lal Pathlabs Share Price

1502.70 21.85 (1.48%) Nov 13, 18:51
1 Year Price Chart
Company Name CMP
Apollo Hospital Ent. 1389.80
Aster DM Healthcare 145.95
Narayana Hrudayalay 301.60
Dr Lal Pathlabs 1502.70
Indraprastha Medical 41.70
View more..
Sensex vs Dr Lal Pathlabs
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719